CalciMedica (CALC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.04, -3.70% vs the prior close of $1.08.
- Volume 13.50K shares, 0.2x its 50-day average (light).
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
CALC slides 3.7% to $1.04, a 52-week low. Closed at $1.04, -3.70% vs the prior close of $1.08. Day range $1.04–$1.22, opened at $1.05.
CALC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CALC slides 3.7% to $1.04, a 52-week low
- Closed at $1.04, -3.70% vs the prior close of $1.08. Day range $1.04–$1.22, opened at $1.05.
- Volume was 13.50K shares, 0.2x its 50-day average of 78.08K — lighter than usual.
- Price is -51.4% vs its 50-day average ($2.14) and -80.8% vs its 200-day average ($5.42).
- 52-week range $1.03–$36.00; today's close sits at 0% of that range, 97.1% below the 52-week high.
Oct 15, 2026 — CALC rises 0.9% to $1.08
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $1.05–$1.15, opened at $1.08.
- Volume was 22.50K shares, 0.3x its 50-day average of 78.54K — lighter than usual.
- Price is -50.7% vs its 50-day average ($2.19) and -80.6% vs its 200-day average ($5.56).
- 52-week range $1.03–$36.00; today's close sits at 0% of that range, 97.0% below the 52-week high.
Oct 14, 2026 — CALC slides 4.5% to $1.07, a 52-week low, 9 down days in a row
- Closed at $1.07, -4.46% vs the prior close of $1.12. Day range $1.03–$1.20, opened at $1.10.
- Volume was 41.20K shares, 0.5x its 50-day average of 78.51K — lighter than usual.
- Price is -52.3% vs its 50-day average ($2.25) and -81.2% vs its 200-day average ($5.70).
- 52-week range $1.03–$36.00; today's close sits at 0% of that range, 97.0% below the 52-week high.
- That makes 9 straight losses.
Oct 13, 2026 — CALC slides 7.1% to $1.12, a 52-week low, 8 down days in a row
- Closed at $1.12, -7.05% vs the prior close of $1.21. Day range $1.09–$1.23, opened at $1.22.
- Volume was 98.80K shares, 1.2x its 50-day average of 81.07K.
- Price is -51.4% vs its 50-day average ($2.30) and -80.9% vs its 200-day average ($5.85).
- 52-week range $1.09–$36.00; today's close sits at 0% of that range, 96.9% below the 52-week high.
- That makes 8 straight losses.
Oct 12, 2026 — CALC slides 5.1% to $1.21, a 52-week low, 7 down days in a row
- Closed at $1.21, -5.12% vs the prior close of $1.27. Day range $1.19–$1.27, opened at $1.27.
- Volume was 74.90K shares, 0.9x its 50-day average of 81.63K.
- Price is -48.9% vs its 50-day average ($2.36) and -79.9% vs its 200-day average ($6.00).
- 52-week range $1.19–$36.00; today's close sits at 0% of that range, 96.7% below the 52-week high.
- That makes 7 straight losses.
Oct 9, 2026 — CALC dips 2.3% to $1.27, a 52-week low, 6 down days in a row
- Closed at $1.27, -2.31% vs the prior close of $1.30. Day range $1.27–$1.34, opened at $1.30.
- Volume was 82.10K shares, 1.0x its 50-day average of 81.24K.
- Price is -47.8% vs its 50-day average ($2.43) and -79.3% vs its 200-day average ($6.15).
- 52-week range $1.27–$36.00; today's close sits at 0% of that range, 96.5% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — CALC slides 12.2% to $1.30, a 52-week low on 2.8x normal volume
- Closed at $1.30, -12.16% vs the prior close of $1.48. Day range $1.30–$1.50, opened at $1.46.
- Volume was 221.30K shares, 2.8x its 50-day average of 77.97K — unusually heavy trading.
- Price is -47.8% vs its 50-day average ($2.49) and -79.4% vs its 200-day average ($6.30).
- 52-week range $1.30–$36.00; today's close sits at 0% of that range, 96.4% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — CALC dips 0.7% to $1.48, a 52-week low, 4 down days in a row
- Closed at $1.48, -0.67% vs the prior close of $1.49. Day range $1.46–$1.49, opened at $1.49.
- Volume was 7.70K shares, 0.1x its 50-day average of 78.42K — lighter than usual.
- Price is -41.7% vs its 50-day average ($2.54) and -77.1% vs its 200-day average ($6.45).
- 52-week range $1.42–$36.00; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — CALC slides 3.2% to $1.49, a 52-week low on 2.2x normal volume
- Closed at $1.49, -3.25% vs the prior close of $1.54. Day range $1.42–$1.61, opened at $1.53.
- Volume was 169.10K shares, 2.2x its 50-day average of 75.85K — unusually heavy trading.
- Price is -42.3% vs its 50-day average ($2.58) and -77.3% vs its 200-day average ($6.57).
- 52-week range $1.42–$36.00; today's close sits at 0% of that range, 95.9% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — CALC slides 3.8% to $1.54, a 52-week low
- Closed at $1.54, -3.75% vs the prior close of $1.60. Day range $1.53–$1.62, opened at $1.62.
- Volume was 26.60K shares, 0.3x its 50-day average of 76.40K — lighter than usual.
- Price is -41.3% vs its 50-day average ($2.62) and -77.0% vs its 200-day average ($6.68).
- 52-week range $1.53–$36.00; today's close sits at 0% of that range, 95.7% below the 52-week high.
Oct 2, 2026 — CALC slides 3.0% to $1.60, a 52-week low
- Closed at $1.60, -3.03% vs the prior close of $1.65. Day range $1.58–$1.70, opened at $1.64.
- Volume was 21.70K shares, 0.3x its 50-day average of 76.45K — lighter than usual.
- Price is -40.0% vs its 50-day average ($2.67) and -76.5% vs its 200-day average ($6.81).
- 52-week range $1.58–$36.00; today's close sits at 0% of that range, 95.6% below the 52-week high.
CALC latest news & SEC filings
Every SEC filing by or about CALC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 30, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 23, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 25, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 24, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CALC
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 3, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.42% (largest 12.2%). That is a volatile stock.
- Liquidity: about 61.07K shares (≈$63.51K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.04 vs a range of $1.03–$36.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:5 on Aug 31, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Fred A Middleton bought 248,972 shares on Jun 25, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Sep 30, 2026; 8-K Sep 16, 2026.
- Share count: 34.14M shares outstanding (Aug 5, 2026), +144.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CALC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.05 | 1.22 | 1.04 | 1.04 | 13.50K |
| Oct 15, 2026 | 1.08 | 1.15 | 1.05 | 1.08 | 22.50K |
| Oct 14, 2026 | 1.10 | 1.20 | 1.03 | 1.07 | 41.20K |
| Oct 13, 2026 | 1.22 | 1.23 | 1.09 | 1.12 | 98.80K |
| Oct 12, 2026 | 1.27 | 1.27 | 1.19 | 1.21 | 74.90K |
| Oct 9, 2026 | 1.30 | 1.34 | 1.27 | 1.27 | 82.10K |
| Oct 8, 2026 | 1.46 | 1.50 | 1.30 | 1.30 | 221.30K |
| Oct 7, 2026 | 1.49 | 1.49 | 1.46 | 1.48 | 7.70K |
| Oct 6, 2026 | 1.53 | 1.61 | 1.42 | 1.49 | 169.10K |
| Oct 5, 2026 | 1.62 | 1.62 | 1.53 | 1.54 | 26.60K |
| Oct 2, 2026 | 1.64 | 1.70 | 1.58 | 1.60 | 21.70K |
| Oct 1, 2026 | 1.62 | 1.71 | 1.60 | 1.65 | 25.80K |
| Sep 30, 2026 | 1.67 | 1.67 | 1.60 | 1.62 | 38.60K |
| Sep 29, 2026 | 1.70 | 1.70 | 1.58 | 1.61 | 43.10K |
| Sep 28, 2026 | 1.75 | 1.75 | 1.62 | 1.68 | 26.60K |
| Sep 25, 2026 | 1.73 | 1.76 | 1.62 | 1.75 | 40.80K |
| Sep 24, 2026 | 1.81 | 1.81 | 1.71 | 1.74 | 54.20K |
| Sep 23, 2026 | 1.87 | 1.88 | 1.76 | 1.79 | 65.40K |
| Sep 22, 2026 | 1.93 | 1.98 | 1.76 | 1.87 | 97.00K |
| Sep 21, 2026 | 1.95 | 1.96 | 1.86 | 1.86 | 50.40K |
About CalciMedica
CalciMedica (CALC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LA JOLLA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1534133.
CALC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan Glicklich | Director | Aug 21, 2026 |
| Frederic Guerard | Director | Aug 21, 2026 |
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | Sep 28, 2026 |
| Fred A Middleton | Director | Jun 29, 2026 |
| Eric W Roberts | CHIEF BUSINESS OFFICER | Aug 21, 2026 |
| Allan Shaw | Director | Aug 21, 2026 |
| Robert N Wilson | Director | Aug 21, 2026 |
| Evgeny Zaytsev | Director | Aug 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephen Bardin | Chief Financial Officer | Sep 28, 2026 |
| Michael J. Dunn | President and COO | Apr 7, 2026 |
| Sudarshan Hebbar | Chief Medical Officer | Sep 28, 2026 |
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | Sep 28, 2026 |
| Eric W Roberts | CHIEF BUSINESS OFFICER | Aug 21, 2026 |
| Kenneth A. Stauderman | Chief Scientific Officer | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 25, 2026 | Fred A Middleton | Buy | 248,972 | $0.80 |
| Jun 25, 2026 | Fred A Middleton | Buy | 248,972 | $0.80 |
| Jun 25, 2026 | Fred A Middleton | Buy | 248,972 | $0.80 |
| Jun 25, 2026 | Fred A Middleton | Buy | 248,972 | $0.80 |
CALC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-29.56M | -1.97 | $-21.18M |
| Dec 31, 2024 | — | $-13.70M | -1.22 | $-21.15M |
| Dec 31, 2023 | — | $-34.36M | -7.66 | $-25.73M |
| Dec 31, 2022 | — | $-7.82M | -111.16 | $-11.76M |
| Dec 31, 2021 | — | $-35.82M | -1.69 | $-31.50M |
Latest balance sheet: total assets $19.50M, total liabilities $13.99M, cash $18.62M (as of Jun 30, 2026).
CALC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $3.29 |
| May 12, 2026 | 8-K Item 2.02 (results) | $3.15 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $2.90 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $16.70 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $12.40 |
| May 14, 2025 | 8-K Item 2.02 (results) | $9.56 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $10.35 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $17.00 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $24.00 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CALC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.